APA (7th ed.) Citation

T, M., VJ, C., FJ, D., J, D., & GC, D. (2026). Comparison of pembrolizumab dosing regimens and incidence and severity of immune-related adverse effects: A retrospective, case-control study. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. https://doi.org/10.1093/ajhp/zxag105

Chicago Style (17th ed.) Citation

T, Monson, Cascone VJ, Diaz FJ, Dai J, and Doolittle GC. "Comparison of Pembrolizumab Dosing Regimens and Incidence and Severity of Immune-related Adverse Effects: A Retrospective, Case-control Study." American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists 2026. https://doi.org/10.1093/ajhp/zxag105.

MLA (9th ed.) Citation

T, Monson, et al. "Comparison of Pembrolizumab Dosing Regimens and Incidence and Severity of Immune-related Adverse Effects: A Retrospective, Case-control Study." American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists, 2026, https://doi.org/10.1093/ajhp/zxag105.